All Type of News
Korean drug firms' patent row on rise
Korean drug companies will see the number of patent disputes with overseas counterparts surge next year, with a majority of the cases involving accusations of local drug firms breaching patents, data showed Monday.
...
Green Cross to supply flu vaccine for $12 million
Green Cross Corp., a Korean drug maker, said Monday it has won the order placed by the Pan American Health Organization (PAHO), a regional WHO body, to supply its influenza vaccines, worth $12 million, to South Americ...
Pharmacist selling wet dressings by piece will face 3-year prison term
Pharmacists, who will engage in selling a wound-care wet dressing product by subdividing or pieces, will be sentenced to three years in prison or subject to 10 million in fines, according to the Korea Food and Adminis...
Competition to heat up in domestic anti-hepatitis B drug market
Heated competition in the domestic anti-hepatitis B drug market, which has been dominated by BMS Korea’s Baraclude, is expected from next year because Yuhan Corp. and Boryung Pharm have been deploying aggressive marke...
Warning issued over Pradaxa
The Korea Food and Drug Administration said last Friday that individuals with prosthetic heart valves should not use Pradaxa, after data from a recently stopped clinical trial revealed that the newer blood thinner may...
Wholesalers get tougher on online drug shopping malls
The Korea Pharmaceutical Wholesaler Association (KPWA) has recently demanded that online drug shopping malls operated by Daewoong Pharm and Hanmi Pharm maintain the same drug pricing as the one adopted by drug wholesa...
Dong-A signs out-licensing agreement for novel DPP-IV inhibitor with Alkem India
Dong-A Pharm announced Friday that it has signed an out-licensing agreement for Dong-A’s novel and selective DPP-IV (dipeptidyl peptidase) inhibitor, DA-1229, with Alkem Laboratories, one of the largest pharmaceutical...
Government to back Huons’ sepsis drug development
Huons said Friday it plans to carry out Phase 1 clinical trial for its sepsis drug candidate in Korea as part of a government program to cultivate blockbuster drugs, targeting the international market.
The governm...
Zuellig Phama Korea to help Korean products gain in Asia
Zuellig Phama Korea (ZPK) has unveiled its plan to support Korean drug companies’ advancement into the Asian markets.
In a press interview on Thursday, ZPK’s president Christophe Piganiol said that the firm will h...
KPA welcomes Park’s win
Jo Chan-hwi, a newly elected president of the Korean Pharmaceutical Association (KPA), welcomed Saenuri Party Park Geun-hye’s election to president, demanding the incoming government help promote the intrinsic functio...
